1. Immunosuppression in murine renal cell carcinoma

   • Shahik K. Gregorian
   • Jack R. Battisto

   Original articles Pages: 325 - 334

2. Immunosuppression in murine renal cell carcinoma

   • Shahik K. Gregorian
   • Jack R. Battisto

   Original articles Pages: 335 - 341

3. Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2

   • Avi Eisenthal

   Original articles Pages: 342 - 348

4. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells

   • F. James Primus
   • Tribhuvan K. Pendurthi
   • Jeffrey Schlom

   Original articles Pages: 349 - 357

5. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E₂

   • Futoshi Okada
   • Masuo Hosokawa
   • Hiroshi Kobayashi

   Original articles Pages: 358 - 364

6. Investigations into the route of uptake and pharmacokinetics of intraperitoneally-administered monoclonal antibodies: I. Transdiaphragmatic blockade of the terminal lymphatics in the rat

   • Jeffrey S. Barrett
   • Richard L. Wahl
   • Susan J. Fisher

   Original articles Pages: 365 - 372

7. Indomethacin modulation of Adriamycin-induced effects on multiple cytolytic effector functions

   • Darbie L. Maccubbin
   • Stefan A. Cohen
   • M. Jane Ehrke

   Original articles Pages: 373 - 380

8. The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene

   • Ritva Valavaara
   • Juhani Tuominen
   • Auli Toivanen

   Original articles Pages: 381 - 386